21 CFR 888.3090
§ 888.3090 Intraoperative orthopedic strain sensor.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 888.3090, § 888.3090 Intraoperative orthopedic strain sensor, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/91074
- Permanent ID
ys:prov:91074@1- SHA-256
1b2e64ccd2de4426c058ae9a0daf3799b88be1b5cc3e8750c23fbc61117ea5f9
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. A strain sensor device is an adjunct tool intended to measure strain on an orthopedic implant in the intraoperative setting only. The device is not intended to provide diagnostic information or influence clinical decision making.
(b) Classification. Class II (special controls). The special controls for this device are:
(1) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. The following performance testing must be conducted:
(i) Mechanical testing to evaluate the effect of the device on the mechanical performance of the implant and to characterize the mechanical limits of the components used with the implant; and
(ii) Accuracy and repeatability testing of strain measurements.
(2) Usability testing must evaluate the effect of the device on the performance of the surgical procedure.
(3) The patient-contacting components of the device must be demonstrated to be biocompatible.
(4) Performance testing must support the sterility and shelf life of the patient-contacting components of the device.
(5) Software verification, validation, and hazard analysis must be performed.
(6) Performance data must validate the reprocessing instructions for reusable components of the device.
(7) Performance data must be provided to demonstrate the electromagnetic compatibility (EMC) and electrical safety of the device.
(8) Labeling must include the following:
(i) A shelf life;
(ii) Instructions for use;
(iii) Reprocessing instructions for any reusable components; and
(iv) A statement that the device is not intended to provide diagnostic information or influence clinical decision making.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.